LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 61.61 M

LeMaitre Vascular, Inc. EBITDA is USD 61.61 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 19.52% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 51.55 M, a 27.50% change year over year.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 40.43 M, a -14.74% change year over year.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 47.42 M, a 13.07% change year over year.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 41.94 M, a 54.66% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)